Inventor · disambiguated record
Qiuhong Li
Also filed as: LI QIUHONG
16 granted patents·3 pending applications·35 citations·filing 2010–2024
90Inventor score
Files withUNIV FLORIDA8BEIJING BEISHUTE MATERNITY & CHILD ARTICLES CO LTD3LI QIUHONG3UNIV PENNSYLVANIA3GUANGZHOU INST BIOMED & HEALTH1
Top patents by PatentIndex Score
19 records- 0192US11739130B2Delivery of card protein as therapy for ocular inflammationUNIV FLORIDA·Filed 2021·Granted Aug 29, 2023·2 cites·15 claims
- 0291US11053291B2Delivery of Nrf2 as therapy for protection against reactive oxygen speciesUNIV FLORIDA·Filed 2015·Granted Jul 6, 2021·6 cites·13 claims
- 0391US10314893B2Oral delivery of angiotensin converting enzyme 2 (ACE2) or angiotensin-(1-7) bioencapsulated in plant cells attenuates pulmonary hypertension, cardiac dysfunction and development of autoimmune and experimental induced ocular disordersUNIV PENNSYLVANIA·Filed 2016·Granted Jun 11, 2019·7 cites·6 claims
- 0488US10981961B2Delivery of card protein as therapy for occular inflammationUNIV FLORIDA·Filed 2014·Granted Apr 20, 2021·5 cites·8 claims
- 0581US12415841B2Delivery of card protein as therapy for occular inflammationUNIV FLORIDA·Filed 2023·Granted Sep 16, 2025·0 cites·18 claims
- 0677US2024352085A1Genetically modified probiotics for oral delivery of renin-angiotensin related therapeutic proteins and peptidesUNIV FLORIDA·Filed 2024·Application pending·0 cites
- 0776US12059454B2Oral delivery of angiotensin converting enzyme 2 (ACE2) or angiotensin-(1-7)-bioencapsulated in plant cells attenuates pulmonary hypertension, cardiac dysfunction and development of autoimmune and experimentally induced ocular disordersUNIV PENNSYLVANIA·Filed 2022·Granted Aug 13, 2024·0 cites·12 claims
- 0875US11945853B2Genetically modified probiotics for oral delivery of renin-angiotensin related therapeutic proteins and peptidesUNIV FLORIDA·Filed 2022·Granted Apr 2, 2024·0 cites·21 claims
- 0970US11512326B2Small angiotensin peptide expression system in mammalian cellsLI QIUHONG·Filed 2010·Granted Nov 29, 2022·2 cites·11 claims
- 1068US11241487B2Oral delivery of angiotensin converting enzyme 2 (ACE2) or angiotensin-(1-7)-bioencapsulated in plant cells attenuates pulmonary hypertension, cardiac dysfunction and development of autoimmune and experimentally induced ocular disordersUNIV PENNSYLVANIA·Filed 2020·Granted Feb 8, 2022·0 cites·8 claims
- 1167US12060395B2Delivery of NRF2 as therapy for protection against reactive oxygen speciesUNIV FLORIDA·Filed 2021·Granted Aug 13, 2024·0 cites·19 claims
- 1267US11179281B2Multilayer-structure absorbent core for nursing pad, and method for preparing absorbent coreBEIJING BEISHUTE MATERNITY & CHILD ARTICLES CO LTD·Filed 2014·Granted Nov 23, 2021·1 cites·12 claims
- 1362US10182948B2Method and device for making absorbent cores used in disposable hygiene padLI QIUHONG·Filed 2012·Granted Jan 22, 2019·3 cites·1 claims
- 1461US9248057B2Method of applying bulk glue for nursing pad base film to four corners of sanitary product nursing pad base film and device thereforLI QIUHONG·Filed 2012·Granted Feb 2, 2016·2 cites·2 claims
- 1561US2023022742A1Method for manufacturing an electrochemical cell having a separator membrane for separation of electrodes in the electrochemical cell and a device thereofNANO & ADVANCED MATERIALS INST LTD·Filed 2022·Application pending·0 cites
- 1655US11377479B2Genetically modified probiotics for oral delivery of renin-angiotensin related therapeutic proteins and peptidesUNIV FLORIDA·Filed 2017·Granted Jul 5, 2022·0 cites·19 claims
- 1748USD777332SAbsorbent padBEIJING BEISHUTE MATERNITY & CHILD ARTICLES CO LTD·Filed 2014·Granted Jan 24, 2017·7 cites·1 claims
- 1843US12213551B2Manufacturing process and apparatus for duckbill maskBEIJING BEISHUTE MATERNITY & CHILD ARTICLES CO LTD·Filed 2020·Granted Feb 4, 2025·0 cites·15 claims
- 1939US2018237745A1Method for controlling differentiation of stem cellsGUANGZHOU INST BIOMED & HEALTH·Filed 2016·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Qiuhong Li files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →